Clinical Trials Logo

Clinical Trial Summary

Making a limb transiently ischemic induces ischemic tolerance in distant organs such as the heart. This study aims to evaluate the feasibility, safety and initial efficacy of using briefly repetitive bilateral limb ischemic preconditioning (BLIPC) to protect the brain in octogenarians with symptomatic intracranial arterial stenosis.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01570231
Study type Interventional
Source Capital Medical University
Contact
Status Completed
Phase Phase 1
Start date January 2008
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT01819597 - Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis N/A
Recruiting NCT05844176 - Intracranial Arterial Stenosis in Young Patients
Enrolling by invitation NCT04240119 - Angiogenic Markers in Cerebrovascular Disease (ANFIS)
Recruiting NCT01553643 - A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis Phase 4
Completed NCT02041117 - Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging Phase 4